Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
3.680
+0.310 (9.20%)
At close: Nov 6, 2026, 4:00 PM EST
3.830
+0.150 (4.08%)
Pre-market: Nov 9, 2026, 7:24 AM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $238.33 million as of November 6, 2026. It is the 19,380th most valuable company in the world and the 3,394th biggest in the United States. Its market cap has decreased by 41.21% in one year.
Market Cap
238.33M
Enterprise Value
75.75M
1-Year Change
-41.21%
Global Rank
Country Rank
#3,394 United States
Category
ChartMarket Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $238.33M, a decrease of -34.85%. That is a compound annual growth rate of -7.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 238.33M | -43.91% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 257.97M |
| Camp4 Therapeutics | 254.78M |
| Bicycle Therapeutics | 253.04M |
| Larimar Therapeutics | 249.48M |
| Evommune | 241.34M |
| Abeona Therapeutics | 238.46M |
| Lexeo Therapeutics | 237.10M |
| Vanda Pharmaceuticals | 230.99M |